These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 7700062)
1. The evolving role of angiotensin-converting enzyme inhibition in heart failure: expanding the protective envelope. Teerlink JR J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S32-7. PubMed ID: 7700062 [TBL] [Abstract][Full Text] [Related]
2. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option. Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075 [TBL] [Abstract][Full Text] [Related]
3. Assessing the treatment of congestive heart failure: diuretics, vasodilators, and angiotensin-converting enzyme inhibitors. Chow MS Pharmacotherapy; 1993; 13(5 Pt 2):82S-87S. PubMed ID: 8233997 [TBL] [Abstract][Full Text] [Related]
4. [Side effects of vasodilator therapy in heart failure: risk of hypotension with ACE inhibitors]. Kromer EP; Elsner D; Riegger GA Z Kardiol; 1991; 80 Suppl 2():11-5. PubMed ID: 2024538 [TBL] [Abstract][Full Text] [Related]
5. [The role of ACE inhibitors in heart failure. Lessons of CONSENSUS, SOLVD and V-HeFTII]. Dessì-Fulgheri P; Paci MV; Rappelli A Ann Ital Med Int; 1994 Oct; 9 Suppl():16S-18S. PubMed ID: 7857751 [TBL] [Abstract][Full Text] [Related]
6. [Vasodilator agents in chronic heart failure: which is the best option?]. Corbalán R; Kunstmann S; Jalil J Rev Med Chil; 1993 Jan; 121(1):81-8. PubMed ID: 8235172 [TBL] [Abstract][Full Text] [Related]
7. [Value of ACE inhibitors in heart failure (clinical aspects)]. Riegger AJ Z Kardiol; 1992; 81 Suppl 4():93-6. PubMed ID: 1290309 [TBL] [Abstract][Full Text] [Related]
10. Rationale for the use of combination angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker therapy in heart failure. Carson PE Am Heart J; 2000 Sep; 140(3):361-6. PubMed ID: 10966531 [TBL] [Abstract][Full Text] [Related]
12. Inhibiting the renin-angiotensin system in myocardial infarction and heart failure: lessons from SAVE, VALIANT and CHARM, and other clinical trials. Tokmakova M; Solomon SD Curr Opin Cardiol; 2006 Jul; 21(4):268-72. PubMed ID: 16755193 [TBL] [Abstract][Full Text] [Related]
14. Heart failure treatment with angiotensin-converting enzyme inhibitors in hospitalized Medicare patients in 10 large states. The Large State Peer Review Organization Consortium. Arch Intern Med; 1997 May; 157(10):1103-8. PubMed ID: 9164376 [TBL] [Abstract][Full Text] [Related]
15. [Trends in pharmacological treatment of congestive heart failure]. Halawa B Pol Merkur Lekarski; 1999 Mar; 6(33):152-6. PubMed ID: 10365602 [TBL] [Abstract][Full Text] [Related]
16. ACE inhibitors in early stages of heart failure. Riegger GA Circulation; 1993 May; 87(5 Suppl):IV117-9. PubMed ID: 8485826 [TBL] [Abstract][Full Text] [Related]
17. Effects of angiotensin converting enzyme inhibitors on remodeling in clinical trials. Greenberg BH J Card Fail; 2002 Dec; 8(6 Suppl):S486-90. PubMed ID: 12555162 [TBL] [Abstract][Full Text] [Related]
18. Should all patients with congestive heart failure and dilated cardiomyopathy be treated with vasodilators? Massie BM Cardiovasc Clin; 1990; 21(1):251-62; discussion 263-4. PubMed ID: 2199051 [TBL] [Abstract][Full Text] [Related]
20. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better? Weir MR Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]